skills/venue-templates/references/venue_writing_styles.md
This guide provides an overview of how writing style varies across publication venues. Understanding these differences is essential for crafting papers that read like authentic publications at each venue.
Reviewed: 2026-07-20
Writing conventions are descriptive, not submission requirements. Check the exact venue and article type before treating any element as mandatory.
Scientific writing style exists on a spectrum from broadly accessible to deeply technical:
Accessible ◄─────────────────────────────────────────────► Technical
Nature/Science PNAS Cell IEEE Trans NeurIPS Specialized
│ │ │ │ │ Journals
│ │ │ │ │ │
▼ ▼ ▼ ▼ ▼ ▼
General Mixed Deep Field Dense ML Expert
audience depth biology experts researchers only
| Venue Type | Audience | Tone | Voice | Abstract Style |
|---|---|---|---|---|
| Nature/Science | Educated non-specialists | Accessible, engaging | Active, first-person OK | Flowing paragraphs, no jargon |
| Cell Press | Biologists | Mechanistic, precise | Mixed | Summary + eTOC blurb + Highlights |
| Medical (NEJM/Lancet) | Clinicians | Evidence-focused | Formal | Structured (Background/Methods/Results/Conclusions) |
| PLOS/BMC | Researchers | Standard academic | Neutral | IMRaD structured or flowing |
| IEEE/ACM | Engineers/CS | Technical | Passive common | Concise, technical |
| ML Conferences | ML researchers | Dense technical | Mixed | Numbers upfront, key results |
| NLP Conferences | NLP researchers | Technical | Varied | Task-focused, benchmarks |
High-impact multidisciplinary journals prioritize broad significance over technical depth. The question is not "Is this technically sound?" but "Why should a scientist outside this field care?"
Nature/Science vs. Specialized Journals:
| Element | Nature/Science | Specialized Journal |
|---|---|---|
| Introduction | 3-4 paragraphs, broad → specific | Extensive literature review |
| Methods | Often in supplement or brief | Full detail in main text |
| Results | Organized by finding/story | Organized by experiment |
| Discussion | Implications first, then caveats | Detailed comparison to literature |
| Figures | Conceptual schematics valued | Raw data emphasized |
Nature style:
"We discovered that protein X acts as a molecular switch controlling cell fate decisions during development, resolving a longstanding question about how stem cells choose their destiny."
Specialized journal style:
"Using CRISPR-Cas9 knockout in murine embryonic stem cells (mESCs), we demonstrate that protein X (encoded by gene ABC1) regulates the expression of pluripotency factors Oct4, Sox2, and Nanog through direct promoter binding, as confirmed by ChIP-seq analysis (n=3 biological replicates, FDR < 0.05)."
Medical journals prioritize clinical relevance and patient outcomes. Every finding must connect to practice.
Background: [1-2 sentences on problem and rationale]
Methods: [Study design, setting, participants, intervention, outcomes, analysis]
Results: [Primary outcome with confidence intervals, secondary outcomes, adverse events]
Conclusions: [Clinical implications, limitations acknowledged]
| Study Design | Appropriate Language |
|---|---|
| RCT | "Treatment X reduced mortality by..." |
| Observational | "Treatment X was associated with reduced mortality..." |
| Case series | "These findings suggest that treatment X may..." |
| Case report | "This case illustrates that treatment X can..." |
ML conferences value novelty, rigorous experiments, and reproducibility. The focus is on advancing the state of the art with empirical evidence.
[Paragraph 1: Problem motivation - why this matters]
[Paragraph 2: Limitations of existing approaches]
[Paragraph 3: Our approach at high level]
Our contributions are as follows:
• We propose [method name], a novel approach to [problem] that [key innovation].
• We provide theoretical analysis showing [guarantees/properties].
• We demonstrate state-of-the-art results on [benchmarks], improving over [baseline] by [X%].
• We release code and models at [anonymous URL for review].
ML abstracts are dense and numbers-focused:
"We present TransformerX, a novel architecture for long-range sequence modeling that achieves O(n log n) complexity while maintaining expressivity. On the Long Range Arena benchmark, TransformerX achieves 86.2% average accuracy, outperforming Transformer (65.4%) and Performer (78.1%). On language modeling, TransformerX matches GPT-2 perplexity (18.4) using 40% fewer parameters. We provide theoretical analysis showing TransformerX can approximate any continuous sequence-to-sequence function."
When converting a journal paper to conference format:
When expanding a conference paper to journal:
When targeting Nature/Science/Cell from a specialized venue:
| Venue | Preference | Example |
|---|---|---|
| Nature/Science | Active encouraged | "We discovered that..." |
| Cell | Mixed | "Our results demonstrate..." |
| Medical | Passive common | "Patients were randomized to..." |
| IEEE | Passive traditional | "The algorithm was implemented..." |
| ML Conferences | Active preferred | "We propose a method that..." |
| Venue | First Person | Example |
|---|---|---|
| Nature/Science | Yes (we) | "We show that..." |
| Cell | Yes (we) | "We found that..." |
| Medical | Sometimes | "We conducted a trial..." |
| IEEE | Less common | Prefer "This paper presents..." |
| ML Conferences | Yes (we) | "We introduce..." |
| Claim Strength | Language |
|---|---|
| Strong | "X causes Y" (only with causal evidence) |
| Moderate | "X is associated with Y" / "X leads to Y" |
| Tentative | "X may contribute to Y" / "X suggests that..." |
| Speculative | "It is possible that X..." / "One interpretation is..." |
❌ Too technical: "We used CRISPR-Cas9 with sgRNAs targeting exon 3..." ✅ Accessible: "Using gene-editing technology, we disabled the gene..."
❌ Dry opening: "Protein X is involved in cellular signaling..." ✅ Engaging opening: "How do cells decide their fate? We discovered that..."
❌ Vague contributions: "We present a new method for X" ✅ Specific contributions: "We propose Method Y that achieves Z% improvement on benchmark W"
❌ Missing ablations: Only showing full method results ✅ Complete: Table showing contribution of each component
❌ Missing absolute numbers: "50% reduction in risk" ✅ Complete: "50% relative reduction (ARR 2.5%, NNT 40)"
❌ Causal language for observational data: "Treatment caused improvement" ✅ Appropriate: "Treatment was associated with improvement"
nature_science_style.md - Detailed Nature/Science writing guidecell_press_style.md - Cell family journal conventionsmedical_journal_styles.md - NEJM, Lancet, JAMA, BMJ guideml_conference_style.md - NeurIPS, ICML, ICLR, CVPR conventionscs_conference_style.md - ACL, CHI, SIGKDD guidereviewer_expectations.md - What reviewers look for by venue